Literature DB >> 12699746

A novel metal-chelating inhibitor of protein farnesyltransferase.

Akiyuki Hamasaki1, Hayato Naka, Fuyuhiko Tamanoi, Kazuo Umezawa, Masami Otsuka.   

Abstract

A novel metal chelator comprising a 4-(naphthalen-1-yl)pyridine and 2-aminoethanethiol was synthesized. This showed inhibitory activity against human protein farnesyltransferase with IC(50) 1.9 microM, induced morphological change in K-ras-NRK cells at 0.5 microg/mL and showed growth inhibition of K-ras-NRK cells with IC(50) 0.32 microg/mL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12699746     DOI: 10.1016/s0960-894x(03)00183-5

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Fighting cancer by disrupting C-terminal methylation of signaling proteins.

Authors:  Steven Clarke; Fuyuhiko Tamanoi
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

2.  Novel Inhibitor for Downstream Targeting of Transforming Growth Factor-β Signaling to Suppress Epithelial to Mesenchymal Transition and Cell Migration.

Authors:  Tsugumasa Toma; Hiroshi Tateishi; Kensaku Kawakami; Taha F S Ali; Masahiro Kamo; Kazuaki Monde; Yuta Nakashima; Mikako Fujita; Masami Otsuka
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 5.923

3.  Blockade of TGF-β/Smad signaling by the small compound HPH-15 ameliorates experimental skin fibrosis.

Authors:  Vu Huy Luong; Takenao Chino; Noritaka Oyama; Takashi Matsushita; Yoko Sasaki; Dai Ogura; Shin-Ichiro Niwa; Tanima Biswas; Akiyuki Hamasaki; Mikako Fujita; Yoshinari Okamoto; Masami Otsuka; Hironobu Ihn; Minoru Hasegawa
Journal:  Arthritis Res Ther       Date:  2018-03-15       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.